Skip to main content

Abstract

Losing a loved one is one of life’s greatest stressors. Although most bereaved individuals navigate through a period of intense acute grief that lessens with time, approximately 10% will develop a prolonged grief condition. This review provides an overview of the course of grief and describes risk factors for developing prolonged grief disorder. The evolution of the prolonged grief disorder diagnosis, including the latest criteria sets for ICD-11 and DSM-5, as well as common comorbid conditions and differential diagnosis are discussed. Clinically useful self-report and clinician-rated measures for assessing symptom constructs and overall prolonged grief disorder severity, evidence-based psychotherapies (such as complicated grief treatment), as well as evidence about pharmacologic approaches are presented. Finally, the authors discuss important future directions, including a potential increase in prolonged grief disorder cases due to the COVID-19 pandemic.

Grief Course and Risk Factors

The loss of a loved one is among life’s most challenging yet common stressors, resulting in the cascade of emotional, cognitive, and behavioral responses that define grief. Grief responses are not based on predefined stages but rather follow heterogeneous patterns as people adapt to an important death (1). Trajectory models assessing the course of grief following a loss for up to 3 years postloss have identified several patterns (13). The most common trajectory following a loss is stable, low levels of grief symptoms; this trajectory occurs for approximately 26%–45% of bereaved individuals (2, 3). In addition, many individuals will experience high (16%–20%) or moderate (30%–33%) levels of grief immediately postloss that decrease over time, often without intervention (2, 3). Furthermore, a small subgroup of individuals (10%) may develop grief later, showing low levels initially and higher levels 6 months postloss; this trajectory has been reported for some bereaved partners (1, 3). Finally, a minority of individuals (approximately 7%–10%) will evidence stable, high-grief trajectories; this subgroup probably represents the subgroup with a prolonged grief condition and will likely warrant intervention if persistent symptoms are linked to distress or functional impairment (24).
As noted, most people who experience an important death manage to successfully adapt to the loss over time, and grief progresses from an acute to a more integrated form. An individual who has lost more than one loved one may experience acute grief differently for different deaths, depending on a variety of factors, including the nature of the relationship to the deceased as well as other circumstances associated with the specific death. Acute grief usually involves a period of intense emotions with preoccupation with thoughts and memories of the deceased person that may result in a period of reduced engagement with life and prior activities. Acute grief varies in its intensity and length, and it has both religious and cultural influences.
For most bereaved individuals, this period of acute grief is followed by integrated grief, meaning the individual has adapted to the loss so that grief is more in the background and they can meaningfully reengage in a life without the deceased (1). Integrated grief outcomes, occurring approximately 6–12 months postloss, have been observed in multiple longitudinal population studies, including prospective studies measuring well-being before and after the loss (58). Relatively low rates of psychopathology after a death are consistent with high levels of resilience seen after other traumatic events (e.g., combat trauma, accidents) (9).
Nevertheless, a significant minority will experience unrelenting bereavement responses resulting in functional impairment beyond cultural norms, which historically has been labeled complicated, traumatic, persistent, or pathological; however, most recently, the consensus name is prolonged grief disorder (10). Prolonged grief disorder is characterized by elevated and persistent mental distress following the loss. Factors that may contribute to prolonged grief reactions are maladaptive thoughts (e.g., blame), avoidance behaviors, inability to manage painful emotions, differences in health and social status, and lack of social support that interferes with adaptation to loss (1113). Prolonged grief disorder is associated with negative outcomes that result in higher risk of all-cause mortality (14). Prolonged grief disorder is associated with higher risk for suicidal ideation and behaviors, even when controlling for depression and posttraumatic stress disorder (PTSD) (15), and is further pronounced for survivors of suicide (16, 17). Data from clinical research settings suggest anywhere from 20% to >50% of treatment-seeking individuals endorse suicidal ideation (1820). Moreover, prolonged grief reactions are uniquely associated with general health impairments (11), including cancer and health problems (21), as well as increased substance use (22).
Although much research is improving the understanding of grief and associated psychopathology, the predictors and etiology of these diverse outcomes remain insufficiently understood. Some studied risk factors for development of prolonged grief include demographic characteristics, preexisting psychiatric conditions, nature of the death, and inadequate social support. Demographic risk factors include female gender, older age, and lower socioeconomic status (23). Prolonged grief prevalence is also higher among individuals with a history of a mood disorder (e.g., bipolar disorder, major depression) (24, 25) as well as those who experienced childhood adversity (26). Furthermore, depression that is present in early bereavement may increase risk of developing prolonged grief (27). Those bereaved by sudden losses (e.g., suicide, homicide, or accident) also may be more likely to develop prolonged grief conditions (27). In addition, bereaved caregivers may have unique risk factors; development of prolonged grief in this population is predicted by severe preloss grief and depressive symptoms, being a partner of the deceased, and education level (28).

Diagnosis of Prolonged Grief Disorder

Diagnostic Criteria

Prolonged grief disorder was only recently included as a codable diagnosis in the World Health Organization’s ICD-11 (29); it has recently been approved but not yet published by the American Psychiatric Association for the revision of the DSM-5 (the most recent available diagnostic criteria for ICD-11 and DSM-5 can be found in Table 1) (30). However, several proposed criteria sets for prolonged grief conditions, labeled pathological grief (31, 32), prolonged grief (10), and complicated grief (11), have existed before these recent additions. The first criteria set for a prolonged grief diagnosis in the DSM-5 was persistent complex bereavement disorder (33), included as a provisional diagnosis for further study.
TABLE 1. ICD-11 and DSM-5-TR prolonged grief disorder criteria
ICD-11 prolonged grief disorder criteriaaProposed prolonged grief disorder criteria for DSM-5-TRb
History of bereavement after the death of a partner, parent, child, or other loved oneThe death, at least 12 months ago, of a person who was close to the bereaved individual (for children and adolescents, at least 6 months ago).
At least one of the following symptoms: A persistent and pervasive longing for the deceased; a persistent and pervasive preoccupation with the deceasedSince the death, the development of a persistent grief response characterized by one or both of the following symptoms, which have been present most days to a clinically significant degree: intense yearning/longing for the deceased person, and preoccupation with thoughts or memories of the deceased person (in children and adolescents, preoccupation may focus on the circumstances of the death). In addition, the symptom(s) have occurred nearly every day for at least the last month.
At least one symptom of intense emotional pain: sadness, guilt, anger, denial, blame; difficulty accepting the death; feeling one has lost a part of one’s self; an inability to experience positive mood; emotional numbness; difficulty in engaging with social or other activitiesSince the death, at least 3 of the following symptoms have been present most days to a clinically significant degree: identity disruption (e.g., feeling as though part of oneself has died) since the death; marked sense of disbelief about the death; avoidance of reminders that the person is dead (in children and adolescents, may be characterized by efforts to avoid reminders); intense emotional pain (e.g., anger, bitterness, sorrow) related to the death; difficulty reintegrating into one’s relationships and activities after the death (e.g., problems engaging with friends, pursuing interests, or planning for the future); emotional numbness (absence or marked reduction of emotional experience) as a result of the death; feeling that life is meaningless as a result of the death; intense loneliness as a result of the death. In addition, the symptoms have occurred nearly every day for at least the last month.
The disturbance causes significant impairment in personal, family, social, educational, occupational, or other important areas of functioning.The disturbance causes clinically significant distress or impairment in social, occupational, or other important areas of functioning.
Time and impairment: persisted for an abnormally long period of time (more than 6 months at a minimum); following the loss, clearly exceeding expected social, cultural, or religious norms for the individual’s culture and contextThe duration and severity of the bereavement reaction clearly exceeds expected social, cultural or religious norms for the individual’s culture and context. The symptoms are not better explained by major depressive disorder, posttraumatic stress disorder, or another mental disorder, or attributable to the physiological effects of a substance (e.g., medication, alcohol) or another medical condition.
a
Source: Killikelly and Maercker (30).
b
Source: Moran M, “Board Approves New Prolonged Grief Disorder for DSM.” Psychiatric News, published online Oct 28, 2020 (https://psychnews.psychiatryonline.org/doi/10.1176/appi.pn.2020.11a12).
The most recent diagnostic criteria sets for prolonged grief disorder have some similarities and some differences, which are largely reflective of the less proscribed nature of ICD versus DSM criteria in general. Otherwise, the most notable difference is the timeframe criterion, as prolonged grief disorder in the DSM-5 requires the death to have occurred at least 12 months before diagnosis as opposed to 6 months prior. Both criteria sets include gateway symptoms of yearning or preoccupation with thoughts or memories of the deceased. The DSM-5 criteria set requires at least three other symptoms occurring nearly every day for at least the past month. The DSM-5 diagnosis of prolonged grief disorder will likely remain in the Trauma and Other Stressor-Related Disorders section, like the provisional persistent complex bereavement disorder diagnosis.

Differential Diagnosis

Common differential diagnoses to consider when evaluating the potential presence of prolonged grief include major depressive disorder, PTSD, and normative or acute grief. Although initial postloss reactions commonly include intense emotions, these emotions do not, for the vast majority of the bereaved, represent the early development of prolonged grief. Acute grief following a loss, particularly the death of a loved one with a strong attachment, is normative and should not be pathologized. Typical signs of acute grief, some of which overlap with prolonged grief disorder, include feelings of shock or disbelief, yearning, waves of sadness or other intense emotions, feeling disconnected from others, and desire to disengage from roles or responsibilities (12, 34). Of note, in the DSM-5, bereavement was no longer listed as exclusionary for assignment of a major depressive disorder diagnosis; however, this diagnosis should be carefully assessed and differentiated from acute grief.
During the acute grief period, bereaved individuals benefit from compassionate support, stabilization of physiological hyperarousal (e.g., sleep interventions), connection to social support systems, and space to oscillate between pain and respite, with encouragement of self-care activities (35). Because prolonged grief disorder cannot be formally diagnosed until 6–12 months after a death, ongoing assessment of an acute grief reaction for those with elevated risk for developing prolonged grief disorder (e.g., preexisting psychiatric history) is recommended; in addition, awareness is needed of the possibility of anniversary reactions, with potential brief heightened grief intensity at important dates, including the 12-month mark. Nonetheless, individuals presenting to clinicians with acute grief may also have other negative outcomes associated with the death; these individuals should be carefully assessed for other common mental health conditions after a major life stressor, such as adjustment disorders, major depressive disorder, PTSD, and elevated risk of suicide (15, 36). As sufficient time passes (at least 6 months in ICD-11 and 12 months in DSM-5) such that prolonged grief disorder may be present, these same conditions, as well as alcohol and substance use disorders, remain the most common to consider in evaluating bereaved individuals.
Major depressive disorder has several overlapping characteristics with prolonged grief disorder, including sadness, crying, social isolation and withdrawal, sleep disturbance, worthlessness and guilt, and suicidal ideation. However, they have been demonstrated to be distinct syndromes despite some overlap in worthlessness and guilt as well as suicidal ideation (37). Typically, sadness, tearfulness, and social isolation are more generalized in major depressive disorder, with evidence of a generalized anhedonia with low reactivity. In prolonged grief disorder, these symptoms are more specifically related to the loss of a close attachment and may include yearning for reunion with the deceased as well as proximity seeking; in addition, avoidance of painful reminders of the permanence of the death can contribute to isolation and functional impairment, such as avoidance of previously shared friends or activities when a spouse dies. This behavior is in contrast to the general withdrawal and low motivation associated with major depressive disorder. Although not diagnostic in prolonged grief disorder, both conditions can also be associated with suicidal ideation and behaviors (15, 37).
PTSD and prolonged grief disorder also have some overlapping features, whether or not a sudden violent or accidental loss occurred, instances that would be considered criterion A traumas within the PTSD diagnostic framework (38). In fact, some models of prolonged grief disorder have described the condition as a combination of traumatic distress and attachment loss (3941). Overlapping features of PTSD and prolonged grief disorder may include intrusive thoughts or images of the death, avoidance related to the death, and emotional numbness. Although not diagnostic in prolonged grief disorder, both conditions can also be associated with sleep disturbance (42).
As both diagnoses are categorized as trauma and stressor-related disorders in the DSM-5, they have some degree of overlap (37). However, distinguishing features exist. For example, the predominant emotion in PTSD is fear, whereas yearning and sadness are more common in prolonged grief disorder (11, 43). The content of intrusive thoughts in PTSD is related to the traumatic event; in prolonged grief disorder, the content is related to the circumstances of the death, although this content may overlap in the case of a violent or accidental death. Avoidance in PTSD is typically related to safety concerns or reducing potential threat, whereas avoidance in prolonged grief disorder is related to avoiding painful reminders of the loss and its permanence. Furthermore, the presence of hyperarousal and hypervigilance has been more typically associated with PTSD, whereas challenges reengaging in life without the deceased (e.g., meaninglessness, wish to join the deceased, loneliness) are associated with prolonged grief disorder (37).

Common Comorbid Conditions

Psychiatric comorbid conditions are common for individuals with prolonged grief disorder and require careful assessment, especially given the aforementioned challenges with differential diagnosis driven in part by some symptom overlap (not unlike what is seen for other disorders triggered by trauma and stressors). For example, in a sample of 206 individuals with prolonged grief disorder, 75% were diagnosed as having a current comorbid psychiatric condition (44). In this sample, the most common comorbid conditions were major depressive disorder (55%), PTSD (48%), and anxiety disorders (62%), with generalized anxiety disorder being the most common anxiety disorder comorbidity (18%) (44).
It is perhaps not surprising that a significant proportion of comorbid conditions present among patients with prolonged grief disorder onset before the death, as these conditions may interfere with adaptation after a death. Indeed, population-based prospective studies of bereaved caregivers have indicated that preloss grief and depressive symptoms, as well as poorer preloss mental health scores on the 36-item Short Form Survey, predict development of prolonged grief disorder postloss (28, 45). Furthermore, studies have also found higher rates of prolonged grief conditions among bereaved samples presenting with major depressive disorder (25, 46), anxiety disorders (46, 47), and trauma-related disorders (46). Threshold levels of prolonged grief symptoms were also associated with poorer quality of life and greater functional impairment (25, 47), suggesting the need to screen patients presenting with mood, anxiety, or trauma-related disorders for exposure to a death and associated prolonged grief disorder. Furthermore, those with prolonged grief disorder may be at elevated risk for suicidal ideation and behaviors; therefore, suicide risk should be adequately assessed (15, 46).
Other comorbid conditions include alcohol and substance use. As with mood and anxiety disorders, those with preexisting substance misuse may be more vulnerable to developing prolonged grief disorder (47). The presence of prolonged grief disorder may also be linked to increases in smoking (48) or alcohol misuse for those with bipolar disorder (24) and major depressive disorder (25). A recent systematic review of 85 studies (N=12,294 participants) indicated that bereaved individuals are also at elevated risk for experiencing a variety of sleep impairments, including poorer sleep quality, problems falling asleep, shorter sleep duration, and anxious nighttime awakenings (42). Furthermore, it estimated that approximately 80% of individuals with prolonged grief conditions experienced long-term poor sleep (42).

Prolonged Grief Disorder Assessment

Assessments (4955) are presented in more detail in Table 2.
TABLE 2. Prolonged grief disorder assessment measures
AssessmentDescriptionScalingScoring
Self-report measures
Brief Grief Questionnaire (49)Five-item, brief-screening, self-report measure that assesses grief-related symptoms0=not at all, 1=somewhat, 2=a lotRange=0–10. Total score≥8 indicates probable prolonged grief disorder. Total scores from 5 to 7 indicate subthreshold prolonged grief disorder.
Inventory of Complicated Grief (50)19-item, self-report measure assessing grief severity0=never, 1=rarely, 2=sometimes, 3=often, 4=alwaysRange=0–76. Clinical cutoff≥25 or≥30.
Prolonged Grief Disorder-13 (51)13-item, self-report measure that assesses grief-related feelings, thoughts, and actionsDuration and impairment rated as yes or no; 11 other items rated 1 (not at all) to 5 (several times a day or overwhelmingly)Range=11–55. Scored by summing the symptom items after excluding the two yes or no items. Suggested clinical cutoff≥35.
Diagnostic interviews
Structured Clinical Interview for Complicated Grief (52)31-item, clinician-administered interview that assesses prior month grief symptoms to determine prolonged grief disorder diagnosis1=not present, 2=unsure or equivocal, 3=presentRange=31–93. As yet, no suggested clinical cutoff. Used to supplement clinical judgment of diagnosis.
Clinician-Administered Prolonged Grief Disorder ScaleaScale assessing clusters of symptoms, including yearning and emotional pain; cognitive, emotional, and behavioral symptoms; symptom onset and duration; and distress and impairment0=absent, 1=mild and subthreshold, 2=moderate, 3=severe, 4=extreme and incapacitatingPsychometric evaluation ongoing.
Assessments of select grief characteristics
Yearning in Situations of Loss Scale-Bereaved (53)21-item, self-report measure of longing for the deceased1=never, 3=sometimes, 5=alwaysRange=21–105. No currently suggested cutoff.
Typical Beliefs Questionnaire (54)25-item, self-report measure of maladaptive thoughts related to grief0=not at all, 1=somewhat, 2=moderately, 3=strongly, 4=very stronglyRange=0–100 raw total, 0–25 dichotomized. Scoring can be continuous total scores or dichotomous scoring (3 or 4 is endorsed).
Grief-Related Avoidance Questionnaire (55)15-item, self-report measure assessing grief-related physical and mental avoidance behaviors0=never, 1=rarely, 2=sometimes, 3=often, 4=alwaysRange=0–60. Total score calculated through summing. Factor-based subscales include reminder of loss, reminder of death, and sympathy situation.

Screening Questionnaires (Self-Report)

Routine screening for prolonged grief disorder in psychiatric settings could improve familiarity with the disorder and accelerate treatment access for patients (56, 57). The Prolonged Grief Disorder-13 (PG-13) has been used in several studies to assess prolonged grief disorder diagnostic criteria (51, 58, 59). This 13-item, self-report measure examines three facets of prolonged grief symptoms: feelings, thoughts, and actions occurring over the past month (10). Initial questions query the frequency of separation distress, specifically yearning or intense feelings of emotional pain, which must have occurred most days over the past 6 months. Subsequent questions are about the extent of cognitive, emotional, and behavioral problems resulting from a loss; a final question assesses significant impairment due to prolonged grief disorder. The PG-13 questions align closely with the ICD-11 diagnostic criteria for prolonged grief disorder. The reliability of the PG-13 ranges from good to excellent (Cronbach’s α=0.84–0.92) (6062) with demonstrated construct and criterion validity (60, 62).
If a shorter tool is needed, the Brief Grief Questionnaire (BGQ) is a five-item, self-report instrument designed to screen for prolonged grief disorder (49, 63). The BGQ has good internal consistency (Cronbach’s α=0.82) and discriminant validity, discriminating grief-related symptoms from general psychological distress (56, 57, 63). A BGQ score≥8 indicates probable prolonged grief disorder, and scores from 5 to 7 indicate subthreshold prolonged grief disorder (63).
The Inventory of Complicated Grief (ICG) (50) is a 19-item measure assessing severity of prolonged grief disorder symptoms; it has been widely used in treatment studies before the establishment of prolonged grief disorder as a diagnosis. The ICG has excellent internal consistency (Cronbach’s α=0.94) and good convergent validity with other grief symptom measures (50). The typical score threshold for inclusion in prolonged grief disorder research has been an ICG score of ≥30 (43, 64); however, recommended clinical cutoff can include scores≥25, suggesting a level of grief with significant social, mental, and physical impairments (50, 65).

Diagnostic Interviews

Clinical evaluation of patients with potential prolonged grief disorder should include consideration of current and lifetime psychiatric disorders, suicidal ideation, mental status, and medical and treatment history (66). This information can be gathered by using a structured assessment, such as the Structured Clinical Interview for DSM-5 (SCID-5) (67) or the Mini-International Neuropsychiatric Interview for DSM-5 (MINI) (68).
However, because prolonged grief disorder was not yet finalized as a diagnosis in the DSM-5, standard assessments such as the SCID-5 and MINI do not yet include prolonged grief disorder (56). Clinicians must therefore assess the severity and intensity of prolonged grief disorder symptoms through separate inquiry. One option is the Structured Clinical Interview for Complicated Grief (SCI-CG) (52), a clinician-administered interview that assesses additional information necessary for a prolonged grief disorder diagnosis (56). The SCI-CG contains 31 symptom ratings about the presence of prolonged grief disorder symptoms over the past month and an optional screening section to assess characteristics related to the death, including relationship to the deceased, cause of death, and time since death (52). Some previous research has used the SCI-CG as a supplement to confirm prolonged grief disorder diagnosis for those above self-report threshold (e.g., 69). The SCI-CG has good to excellent psychometric properties, including interrater reliability (intraclass correlation coefficient [ICC]=0.95), internal consistency (Cronbach’s α=0.77), test-retest reliability (ICC=0.68), and convergent validity with other complicated grief symptom measures (52). However, these properties have been validated within just one study (70); overall, Bui et al. (52) found high acceptability of the SCI-CG, with clinicians reporting that they found the instrument easy to conduct and helpful for assessing patients with prolonged grief disorder.
Additional measures are also being used and developed, such as the Clinician-Administered Prolonged Grief Disorder Scale, and will likely further align with the diagnostic criteria as they become official in the revised DSM-5. ICD-11 criteria are more flexible and can also be applied in clinical practice.

Assessment of Select Grief Characteristics

Yearning is considered one of the gateway features of prolonged grief disorder diagnosis and may be integral in starting a cascade of other grief-related symptoms, including emotional pain, preoccupation with the deceased, and feeling life is meaningless without the deceased (37). The Yearning in Situations of Loss Scale–Bereaved (YSL) (53) is a 21-item, self-report measure assessing the extent to which a bereaved person is longing for the deceased. The YSL demonstrates strong psychometric properties, including internal consistency (Cronbach’s α=0.91) and appropriate discriminant validity with constructs such as depression, anxiety, and loneliness (53).
The existence of ruminative, maladaptive cognitions as well as avoidance behavior after a loss have also been shown to contribute to the onset of prolonged grief disorder (7179). Continued avoidance of emotional pain, thoughts, or places associated with the deceased as well as dysfunctional beliefs may interfere with adaptation to the loss and thus promote the development and severity of prolonged grief disorder (54), impairment, and treatment response (28, 35). As these constructs are not fully captured by self-report or clinician-administered measures, specific self-report assessments, such as the Typical Beliefs Questionnaire (TBQ) (54) and the Grief-Related Avoidance Questionnaire (GRAQ) (55), may be administered in addition to the aforementioned measures.
The TBQ is a 25-item, self-report measure of maladaptive thinking patterns common among people with prolonged grief. Scoring can be done through simple summation of all rating scores or through dichotomous scoring, in which a score of “3” or “4” is considered an endorsed item. The TBQ has good psychometric properties, including internal consistency (Cronbach’s α=0.82) and test-retest reliability (ICC=0.74) (54). Factor analysis revealed five relevant factors: protesting the death, negative thoughts about the world, needing the person, less grief is wrong, and grieving too much (54). Of note, cause of death may affect themes of typical beliefs. For example, those bereaved by suicide may be more likely to endorse self-blame as well as feeling less connected to others and stigma-related beliefs (80).
The GRAQ is a 15-item, self-report measure assessing physical and mental avoidance behaviors of bereaved individuals (55). The GRAQ has shown good internal consistency (Cronbach’s α=0.87–0.89) (55, 81) and convergent validity, differentiating between those with and without anxiety, depression, and PTSD symptoms (81). Factor analysis identified three distinct factors: avoidance of places and things that are reminders of the death (reminders of loss), avoidance of activities that are reminders of the death (reminders of death), and avoidance of situations related to illness or death that evoke loss-adjacent emotions (sympathy situations; e.g., going to funerals) (55, 81). In a GRAQ validation study, loss of a child and death due to short illness resulted in the highest levels of grief-related avoidance compared with other relationships and causes of death (81).

Evidence-Based Treatments for Prolonged Grief Disorder

Many bereaved individuals will experience a natural decline in grief-related symptoms over time and will not require any formal intervention. Furthermore, the presence of some grief-related symptoms that do not cause significant distress or interfere with function and that may wax and wane throughout the year, with periods of worsening on important anniversary dates (e.g., date of death), does not alone represent pathology or indicate a need for intervention. However, for the minority who develop the condition of prolonged grief disorder (4), evidence-based, short-term interventions are available that can help ameliorate prolonged grief disorder symptoms. Indeed, a meta-analysis indicated a moderate significant effect of treatment interventions (N=5 studies; standard mean difference=−0.53), particularly those with cognitive-behavioral elements, on improving grief-related outcomes; however, no effect was found for preventive interventions, suggesting that early intervention may not be required (82) or that better understanding and identification of those at risk for indicated prevention would be a better approach. In the subsequent sections, we highlight the primary components and evidence for the most widely-utilized prolonged grief disorder interventions.

Complicated Grief Treatment (CGT)

CGT is a 16-session, manualized intervention, which has demonstrated efficacy for reducing prolonged grief disorder symptoms in several randomized controlled trials (RCTs) (18, 43, 69). CGT incorporates components of attachment theory, cognitive-behavioral therapy (CBT), and other approaches to facilitate natural adaptive processes to loss. CGT facilitates adaptation through focus on both loss and restoration, in alignment with the dual process model of grief (83). The loss-focused components include accepting the reality of the death and changing the relationship with the person who died. The restoration-focused elements include working toward aspirational goals in the absence of the individual who died and having a sense of competence and satisfaction in the world without the deceased (35). To meet the goal of adaptation, CGT includes seven core themes: providing information to help patients understand and accept grief, managing emotional pain and monitoring symptoms, thinking about the future, reconnecting with others, telling the story of the death, learning to live with reminders, and connecting with memories. Previous articles have described the essential tools discussed within each of these themes (35), and training in CGT is available (https://complicatedgrief.columbia.edu).
CGT has demonstrated efficacy compared with interpersonal therapy in two trials across the adult age spectrum, with CGT exhibiting better response rates, greater symptom reduction, and less prolonged grief disorder–related impairment (18, 43). In another RCT of 395 patients with prolonged grief disorder, patients were randomly assigned to receive CGT augmented with the antidepressant citalopram, CGT plus placebo, citalopram only, or placebo only. In this study, those receiving CGT (with citalopram or placebo) showed greater reductions in prolonged grief disorder symptoms and suicidal ideation than those on a pill alone (69). Evidence has also been found that CGT is efficacious compared with treatment as usual when delivered in a group setting (84). Overall, these trials have demonstrated efficacy of CGT as a gold-standard intervention for individuals with prolonged grief disorder.

CBT

Other therapy protocols with some overlap with CGT that specifically include elements of CBT, such as exposure interventions, may also be useful for patients with prolonged grief disorder. For example, patients randomly assigned to group CBT for grief supplemented by four individual sessions of exposure interventions (exposure to the story of the death) demonstrated greater reductions in grief and depressive symptoms, fewer negative appraisals, and improved functioning compared with group CBT supplemented with four individual supportive counseling sessions (85). In another study comparing two cognitive-behavioral interventions (with six sessions of cognitive restructuring and six sessions of exposure therapy delivered in counterbalanced order) with supportive counseling, the two CBT-based interventions showed greater improvement in grief outcomes (86). Healthy Experiences After Loss, an Internet-based intervention that uses cognitive-behavioral strategies to promote reengagement in positive self-care and with social resources, has demonstrated initial benefits for grief, depression, anxiety, and posttraumatic stress in a pilot study (87). Additional protocols for prolonged grief-specific CBT and suicide bereavement are in development (88, 89).
CBT may also be effective in targeting symptoms that typically co-occur with prolonged grief disorder. For example, a majority of patients with prolonged grief disorder report significant sleep disturbance, which may not always improve with grief-focused treatment (90). For these patients, it may be useful to implement a brief, sleep-focused intervention, such as CBT for insomnia (CBT-I). CBT-I has demonstrated efficacy in improving insomnia symptoms (91) and includes components of sleep hygiene, stimulus control, sleep restriction, and cognitive restructuring regarding negative beliefs about sleep. Little research has specifically examined the effects of CBT-I for bereaved individuals, although some evidence has shown that CBT-I may be useful in improving depressive symptoms (92).

Support Groups

Little systematic research has been conducted on the efficacy of support or bereavement groups on grief-related symptoms, although these groups tend to be accessed by many experiencing loss. For example, in a survey of 47 women who experienced a perinatal loss, 50% accessed support group services (93). For those bereaved by suicide, bereavement groups may help lower intensity of acute grief but may not be sufficient for prolonged grief disorder (94). Aligned with this finding, bereavement groups were qualitatively found to be more helpful and meaningful closer to the loved one’s death, but not all participants reported benefit (95). Overall, bereavement groups may be a useful source of social support after a loss because lack of social support is a risk factor for development of prolonged grief (96, 97); however, more research is required to elucidate the effects of bereavement groups on long-term outcomes for individuals with prolonged grief.

Pharmacotherapy

Few studies have investigated the effects of pharmacotherapy alone in the treatment of prolonged grief disorder. A review of the literature identified several early open-label trials of tricyclic antidepressants as well as selective serotonin reuptake inhibitors and other newer generation antidepressants prescribed to bereaved individuals (98). In two small, open-label trials of tricyclics (N=23 total) and one open-label trial of bupropion (N=23), medications significantly improved depression symptoms, but effects on grief intensity were marginal (99101). In an RCT of 80 older adults with bereavement depression, nortriptyline improved depression symptoms but did not have differential effects on improvement rates of grief intensity compared with placebo (102).
Antidepressants in combination with CBT have also been shown to improve comorbid depression symptoms, but they may have limited effects on grief-specific symptoms. In the large four-arm RCT of 395 patients described earlier, citalopram did not outperform placebo in improving prolonged grief disorder symptoms (69). However, receiving CGT in combination with citalopram showed additive benefit for depression symptoms compared with CGT plus placebo; no differences in grief symptoms were found (69). Of note, suicide-bereaved individuals in the citalopram alone group showed lower completion rates than those bereaved by other causes; thus, pharmacotherapy alone may not be warranted for those bereaved by suicide (64). In a naturalistic study examining effects of antidepressant use for individuals in CGT versus interpersonal therapy, those who remained on antidepressants were less likely to drop out of CGT (91% vs. 58% completion rates) and showed a higher response rate (103). Overall, additional rigorous research is warranted to establish evidence-based targets for pharmacotherapy in prolonged grief disorder and to understand the effects of different classes of medications alone and in conjunction with therapy, especially with respect to improvement in grief-related symptoms. In the meanwhile, given the paucity of evidence for grief-specific efficacy, medications may be most clinically useful in the setting of comorbid conditions or to target specific symptoms if patients do not respond to evidence-based psychotherapy.

Future Directions

Coronavirus (COVID-19) Implications

As yet, the COVID-19 pandemic has led to more than 400,000 deaths in the United States and more than 2.14 million deaths worldwide. Additionally, because of restrictions such as social distancing, reduced capacity at events, and hospital regulations, typical grief rituals or mourning processes have been significantly disrupted. Therefore, increased prevalence of mental health conditions, including prolonged grief, may be a “second wave” of the pandemic (104). No previous studies have focused solely on individuals bereaved because of historical pandemics (105). However, research with survivors of pandemics, many of whom are bereaved themselves, has identified several themes that emerged subsequent to pandemics, including multiplicity of loss, uncertainty, and disruption of connectiveness (105). Factors influencing bereavement outcomes, which may be disrupted in the current pandemic and contribute to greater chances of developing prolonged grief disorder, include reduced social connections, disrupted grief rituals, and lack of psychosocial support (105).
Research on acute grief during the COVID-19 pandemic has suggested that higher grief symptom levels are present for those bereaved because of COVID-19 than for those bereaved by natural causes in the same time period, but levels were not unlike unnatural bereavement (106). However, acute grief levels may not be predictive of subsequent prolonged grief disorder. In a cross-sectional survey, no significant differences were found between grief levels before or during the pandemic for people bereaved before the pandemic; however, experiencing a loss during the pandemic was shown to elicit more severe acute grief reactions than for acute grief before the pandemic (107). Because COVID-related losses may not have yet surpassed the 6- to 12-month timeframe required for a prolonged grief disorder diagnosis, ongoing research is required to determine the mental health impact of these losses over time; however, it is important to note that research has shown that only a minority of individuals will develop persistent intense grief that causes distress and impairment. Nonetheless, health care workers may be particularly adversely affected because of higher levels of stress, isolation from friends and family, and exposure to death of patients and colleagues; therefore, these individuals should be closely monitored for anxiety, depression, PTSD, and prolonged grief reactions (108). Resources for education about the management of patients with exposure to personal or workplace COVID-related deaths as well as associated traumatic distress are available through several organizations (109111).

Characterization of Prolonged Grief Disorder

With the new inclusion of prolonged grief disorder in the ICD-11 and DSM-5, future research may utilize advanced computational approaches, such as machine learning, longitudinal trajectories, and network approaches, to better understand differential diagnosis, comorbid conditions, and patterns of prolonged grief disorder development over time. Such approaches have been applied previously with diagnostic criteria sets for complicated grief and persistent complex bereavement disorder (e.g., 37, 112, 113) and from samples assessed with the PG-13 (e.g., 114, 115), which vary slightly from the newly accepted DSM-5 prolonged grief disorder criteria.
Another important direction is to better characterize prolonged grief disorder with a focus on neurobiology and biomarkers. Neurobiological research of prolonged grief disorder using functional magnetic resonance imaging is in its infancy. However, the available evidence suggests neural differences for those with and without prolonged grief disorder. For example, those with prolonged grief disorder demonstrate more activation in the nucleus accumbens when reminded of the deceased, suggesting heightened reward activation associated with the deceased that may impair adjustment to the loss (116). Furthermore, for those with prolonged grief disorder, prefrontal regions may be disrupted during emotion processing (117); in addition, whole brain volume and cognitive function may be different for those with prolonged grief disorder versus normative grief (118).
Few studies have investigated biomarkers of prolonged grief disorder, but initial data suggest future study is warranted. Given the attachment-related nature of prolonged grief disorder, oxytocin, a hormone associated with social connection and bonding, may be implicated. A recent pilot study found higher oxytocin levels among those with prolonged grief disorder compared with those with major depressive disorder; in addition, having threshold levels of prolonged grief disorder on the ICG was associated with higher oxytocin levels (119). Prolonged grief disorder is also categorized as a stress response disorder, which may have implications for immune activation and cortisol responses. Indeed, a review of five studies found that morning cortisol levels were lower for those with prolonged grief disorder, suggesting possible dysregulation of the hypothalamic-pituitary-adrenal axis (120). Overall, more research is needed to understand the neurobiology as well as clinically useful biomarker signatures of prolonged grief disorder. Some potential areas of interest include the biology of stress responses, attachment, and reward.

Conclusions

Grief is a natural response to the loss of a close loved one, and only a subset of bereaved individuals will develop a prolonged grief condition. The ICD-11 and DSM-5 both now have approved diagnostic criteria sets for prolonged grief disorder, which can be diagnosed 6–12 months following a loss and involves hallmark symptoms of yearning or preoccupation with the deceased. Several assessment measures, including self-report and clinician-rated questionnaires, can be used to assess specific grief symptoms and to track progress in treatment over time. Evidence-based approaches, including CGT, exist for treating prolonged grief disorder symptoms in a short-term framework. Future research and clinical work should focus on improving the understanding of potential pharmacotherapy neural targets and the potential role of pharmacological treatments. In addition, the dissemination and implementation of evidence-based prolonged grief disorder psychotherapies should be examined. Finally, the impact of the COVID-19 pandemic on grief-related symptoms should be studied because of the unexpected and sudden losses as well as the inability to perform typical grief rituals or to have the usual social support.

References

1.
Bonanno GA : Loss, trauma, and human resilience: have we underestimated the human capacity to thrive after extremely aversive events? Am Psychol 2004 ; 59 : 20 – 28
2.
Djelantik A, Smid GE, Kleber RJ, et al : Early indicators of problematic grief trajectories following bereavement. Eur J Psychotraumatol 2017 ; 8 ( Suppl 6 ): 1423825
3.
Nielsen MK, Carlsen AH, Neergaard MA, et al : Looking beyond the mean in grief trajectories: a prospective, population-based cohort study. Soc Sci Med 2019 ; 232 : 460 – 469
4.
Lundorff M, Holmgren H, Zachariae R, et al : Prevalence of prolonged grief disorder in adult bereavement: a systematic review and meta-analysis. J Affect Disord 2017 ; 212 : 138 – 149
5.
Bonanno GA, Wortman CB, Lehman DR, et al : Resilience to loss and chronic grief: a prospective study from preloss to 18-months postloss. J Pers Soc Psychol 2002 ; 83 : 1150 – 1164
6.
Galatzer-Levy IR, Bonanno GA : Beyond normality in the study of bereavement: heterogeneity in depression outcomes following loss in older adults. Soc Sci Med 2012 ; 74 : 1987 – 1994
7.
Mancini AD, Bonanno GA, Clark AE : Stepping off the hedonic treadmill: individual differences in response to major life events. J Individ Differ 2011 ; 32 : 144 – 152
8.
Bonanno GA, Malgaroli M : Trajectories of grief: comparing symptoms from the DSM-5 and ICD-11 diagnoses. Depress Anxiety 2020 ; 37 : 17 – 25
9.
Galatzer-Levy IR, Huang SH, Bonanno GA : Trajectories of resilience and dysfunction following potential trauma: a review and statistical evaluation. Clin Psychol Rev 2018 ; 63 : 41 – 55
10.
Prigerson HG, Horowitz MJ, Jacobs SC, et al : Prolonged grief disorder: psychometric validation of criteria proposed for DSM-V and ICD-11. PLoS Med 2009 ; 6 : e1000121
11.
Shear MK, Simon N, Wall M, et al : Complicated grief and related bereavement issues for DSM-5. Depress Anxiety 2011 ; 28 : 103 – 117
12.
Zisook S, Iglewicz A, Avanzino J, et al : Bereavement: course, consequences, and care. Curr Psychiatry Rep 2014 ; 16 : 482
13.
Stroebe M, Schut H, Stroebe W : Health outcomes of bereavement. Lancet 2007 ; 370 : 1960 – 1973
14.
Kaprio J, Koskenvuo M, Rita H : Mortality after bereavement: a prospective study of 95,647 widowed persons. Am J Public Health 1987 ; 77 : 283 – 287
15.
Latham AE, Prigerson HG : Suicidality and bereavement: complicated grief as psychiatric disorder presenting greatest risk for suicidality. Suicide Life Threat Behav 2004 ; 34 : 350 – 362
16.
Prigerson HG, Bridge J, Maciejewski PK, et al : Influence of traumatic grief on suicidal ideation among young adults. Am J Psychiatry 1999 ; 156 : 1994 – 1995
17.
Mitchell AM, Kim Y, Prigerson HG, et al : Complicated grief and suicidal ideation in adult survivors of suicide. Suicide Life Threat Behav 2005 ; 35 : 498 – 506
18.
Shear MK, Wang Y, Skritskaya N, et al : Treatment of complicated grief in elderly persons: a randomized clinical trial. JAMA Psychiatry 2014 ; 71 : 1287 – 1295
19.
Frumkin MR, Robinaugh DJ, LeBlanc NJ, et al : The pain of grief: exploring the concept of psychological pain and its relation to complicated grief, depression, and risk for suicide in bereaved adults. J Clin Psychol 2021 ; 77 : 254 – 267
20.
Szanto K, Prigerson H, Houck P, et al : Suicidal ideation in elderly bereaved: the role of complicated grief. Suicide Life Threat Behav 1997 ; 27 : 194 – 207
21.
Chen JH, Bierhals AJ, Prigerson HG, et al : Gender differences in the effects of bereavement-related psychological distress in health outcomes. Psychol Med 1999 ; 29 : 367 – 380
22.
Parisi A, Sharma A, Howard MO, et al : The relationship between substance misuse and complicated grief: a systematic review. J Subst Abuse Treat 2019 ; 103 : 43 – 57
23.
Kersting A, Brähler E, Glaesmer H, et al : Prevalence of complicated grief in a representative population-based sample. J Affect Disord 2011 ; 131 : 339 – 343
24.
Simon NM, Pollack MH, Fischmann D, et al : Complicated grief and its correlates in patients with bipolar disorder. J Clin Psychiatry 2005 ; 66 : 1105 – 1110
25.
Sung SC, Dryman MT, Marks E, et al : Complicated grief among individuals with major depression: prevalence, comorbidity, and associated features. J Affect Disord 2011 ; 134 : 453 – 458
26.
Vanderwerker LC, Jacobs SC, Parkes CM, et al : An exploration of associations between separation anxiety in childhood and complicated grief in later life. J Nerv Ment Dis 2006 ; 194 : 121 – 123
27.
Guldin MB, Kjaersgaard MIS, Fenger-Grøn M, et al : Risk of suicide, deliberate self-harm and psychiatric illness after the loss of a close relative: a nationwide cohort study. World Psychiatry 2017 ; 16 : 193 – 199
28.
Nielsen MK, Neergaard MA, Jensen AB, et al : Predictors of complicated grief and depression in bereaved caregivers: a nationwide prospective cohort study. J Pain Symptom Manage 2017 ; 53 : 540 – 550
29.
International Statistical Classification of Diseases and Related Health Problems: Instruction Manual, 11th ed. Geneva, World Health Organization, 2020
30.
Killikelly C, Maercker A : Prolonged grief disorder for ICD-11: the primacy of clinical utility and international applicability. Eur J Psychotraumatol 2018 ; 8 ( Suppl 6 ): 1476441
31.
Horowitz MJ, Bonanno GA, Holen A : Pathological grief: diagnosis and explanation. Psychosom Med 1993 ; 55 : 260 – 273
32.
Horowitz MJ, Siegel B, Holen A, et al : Diagnostic criteria for complicated grief disorder. Am J Psychiatry 1997 ; 154 : 904 – 910
33.
Diagnostic and Statistical Manual of Mental Disorders, 5th ed. Arlington, VA, American Psychiatric Publishing, 2013
34.
Bonanno GA, Papa A, Lalande K, et al : Grief processing and deliberate grief avoidance: a prospective comparison of bereaved spouses and parents in the United States and the People’s Republic of China. J Consult Clin Psychol 2005 ; 73 : 86 – 98
35.
Iglewicz A, Shear MK, Reynolds CF III, et al : Complicated grief therapy for clinicians: an evidence-based protocol for mental health practice. Depress Anxiety 2020 ; 37 : 90 – 98
36.
Agerbo E : Risk of suicide and spouse’s psychiatric illness or suicide: nested case-control study. BMJ 2003 ; 327 : 1025 – 1026
37.
Malgaroli M, Maccallum F, Bonanno GA : Symptoms of persistent complex bereavement disorder, depression, and PTSD in a conjugally bereaved sample: a network analysis. Psychol Med 2018 ; 48 : 2439 – 2448
38.
Na PJ, Adhikari S, Szuhany KL, et al : Post-traumatic distress symptoms and their response to treatment in adults with prolonged grief disorder. J Clin Psychiatry ( in press )
39.
O’Connor M, Lasgaard M, Shevlin M, et al : A confirmatory factor analysis of combined models of the Harvard Trauma Questionnaire and the Inventory of Complicated Grief-Revised: are we measuring complicated grief or posttraumatic stress? J Anxiety Disord 2010 ; 24 : 672 – 679
40.
Jacobs S, Mazure C, Prigerson H : Diagnostic criteria for traumatic grief. Death Stud 2000 ; 24 : 185 – 199
41.
Prigerson HG, Frank E, Kasl SV, et al : Complicated grief and bereavement-related depression as distinct disorders: preliminary empirical validation in elderly bereaved spouses. Am J Psychiatry 1995 ; 152 : 22 – 30
42.
Lancel M, Stroebe M, Eisma MC : Sleep disturbances in bereavement: a systematic review. Sleep Med Rev 2020 ; 53 : 101331
43.
Shear K, Frank E, Houck PR, et al : Treatment of complicated grief: a randomized controlled trial. JAMA 2005 ; 293 : 2601 – 2608
44.
Simon NM, Shear KM, Thompson EH, et al : The prevalence and correlates of psychiatric comorbidity in individuals with complicated grief. Compr Psychiatry 2007 ; 48 : 395 – 399
45.
Lenger MK, Neergaard MA, Guldin MB, et al : Poor physical and mental health predicts prolonged grief disorder: a prospective, population-based cohort study on caregivers of patients at the end of life. Palliat Med 2020 ; 34 : 1416 – 1424
46.
Heeke C, Kampisiou C, Niemeyer H, et al : A systematic review and meta-analysis of correlates of prolonged grief disorder in adults exposed to violent loss. Eur J Psychotraumatol 2019 ; 10 : 1583524
47.
Marques L, Bui E, LeBlanc N, et al : Complicated grief symptoms in anxiety disorders: prevalence and associated impairment. Depress Anxiety 2013 ; 30 : 1211 – 1216
48.
Prigerson HG, Bierhals AJ, Kasl SV, et al : Traumatic grief as a risk factor for mental and physical morbidity. Am J Psychiatry 1997 ; 154 : 616 – 623
49.
Shear K, Essock S : Brief Grief Questionnaire. Pittsburgh, University of Pittsburgh, 2002
50.
Prigerson HG, Maciejewski PK, Reynolds CF III, et al : Inventory of Complicated Grief: a scale to measure maladaptive symptoms of loss. Psychiatry Res 1995 ; 59 : 65 – 79
51.
Prigerson HG, Maciejewski PK : Prolonged Grief Disorder (PG-13). Boston, Dana-Farber Cancer Institute, 2006
52.
Bui E, Mauro C, Robinaugh DJ, et al : The Structured Clinical Interview for Complicated Grief: reliability, validity, and exploratory factor analysis. Depress Anxiety 2015 ; 32 : 485 – 492
53.
O’Connor M-F, Sussman TJ : Developing the Yearning in Situations of Loss Scale: convergent and discriminant validity for bereavement, romantic breakup, and homesickness. Death Stud 2014 ; 38 : 450 – 458
54.
Skritskaya NA, Mauro C, Olonoff M, et al : Measuring maladaptive cognitions in complicated grief: introducing the Typical Beliefs Questionnaire. Am J Geriatr Psychiatry 2017 ; 25 : 541 – 550
55.
Shear K, Monk T, Houck P, et al : An attachment-based model of complicated grief including the role of avoidance. Eur Arch Psychiatry Clin Neurosci 2007 ; 257 : 453 – 461
56.
Charney ME, Wieman S, Leblanc N, et al : Persistent complex bereavement disorder ; in Trauma- and Stressor-Related Disorders. Edited by Stoddard FJ, Benedek DM, Milad MR, et al. Oxford, England, Oxford University Press, 2018
57.
Ito M, Nakajima S, Fujisawa D, et al : Brief measure for screening complicated grief: reliability and discriminant validity. PLoS One 2012 ; 7 : e31209
58.
Morina N, von Lersner U, Prigerson HG : War and bereavement: consequences for mental and physical distress. PLoS One 2011 ; 6 : e22140
59.
Steil R, Gutermann J, Harrison O, et al : Prevalence of prolonged grief disorder in a sample of female refugees. BMC Psychiatry 2019 ; 19 : 148
60.
Field NP, Strasser J, Taing S, et al : Prolonged grief following the recent death of a daughter among mothers who experienced distal losses during the Khmer Rouge era: validity of the prolonged grief construct in Cambodia. Psychiatry Res 2014 ; 219 : 183 – 190
61.
Schaal S : Is prolonged grief distinct from depression? J Loss Trauma 2015 ; 20 : 46 – 55
62.
Pohlkamp L, Kreicbergs U, Prigerson HG, et al : Psychometric properties of the Prolonged Grief Disorder-13 (PG-13) in bereaved Swedish parents. Psychiatry Res 2018 ; 267 : 560 – 565
63.
Shear KM, Jackson CT, Essock SM, et al : Screening for complicated grief among Project Liberty service recipients 18 months after September 11, 2001. Psychiatr Serv 2006 ; 57 : 1291 – 1297
64.
Zisook S, Shear MK, Reynolds CF, et al : Treatment of complicated grief in survivors of suicide loss: a HEAL report. J Clin Psychiatry 2018 ; 79 : 17m11592
65.
Anderson WG, Arnold RM, Angus DC, et al : Posttraumatic stress and complicated grief in family members of patients in the intensive care unit. J Gen Intern Med 2008 ; 23 : 1871 – 1876
66.
Simon NM, Shear MK, Reynolds CF, et al : Commentary on evidence in support of a grief-related condition as a DSM diagnosis. Depress Anxiety 2020 ; 37 : 9 – 16
67.
First MB, Williams JB, Karg RS, et al : Structured Clinical Interview for DSM-5-Research Version. Arlington, VA, American Psychiatric Association, 2015
68.
Sheehan DV, Lecrubier Y, Sheehan KH, et al : The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry 1998 ; 59 ( Suppl 20 ): 22 – 57
69.
Shear MK, Reynolds CF III, Simon NM, et al : Optimizing treatment of complicated grief: a randomized clinical trial. JAMA Psychiatry 2016 ; 73 : 685 – 694
70.
Treml J, Kaiser J, Plexnies A, et al : Assessing prolonged grief disorder: a systematic review of assessment instruments. J Affect Disord 2020 ; 274 : 420 – 434
71.
Boelen PA, van Denderen M, de Keijser J : Prolonged grief, posttraumatic stress, anger, and revenge phenomena following homicidal loss: the role of negative cognitions and avoidance behaviors. Homicide Stud 2016 ; 20 : 177 – 195
72.
Boelen PA, Reijntjes A, Djelantik AAAMJ, et al : Prolonged grief and depression after unnatural loss: latent class analyses and cognitive correlates. Psychiatry Res 2016 ; 240 : 358 – 363
73.
Eisma MC, Stroebe MS, Schut HAW, et al : Avoidance processes mediate the relationship between rumination and symptoms of complicated grief and depression following loss. J Abnorm Psychol 2013 ; 122 : 961 – 970
74.
Eisma MC, Schut HAW, Stroebe MS, et al : Adaptive and maladaptive rumination after loss: a three-wave longitudinal study. Br J Clin Psychol 2015 ; 54 : 163 – 180
75.
Kokou-Kpolou K, Megalakaki O, Nieuviarts N : Persistent depressive and grief symptoms for up to 10 years following perinatal loss: involvement of negative cognitions. J Affect Disord 2018 ; 241 : 360 – 366
76.
Morina N : Rumination and avoidance as predictors of prolonged grief, depression, and posttraumatic stress in female widowed survivors of war. J Nerv Ment Dis 2011 ; 199 : 921 – 927
77.
Bonanno GA, Keltner D, Holen A, et al : When avoiding unpleasant emotions might not be such a bad thing: verbal-autonomic response dissociation and midlife conjugal bereavement. J Pers Soc Psychol 1995 ; 69 : 975 – 989
78.
Bowlby J : Attachment and Loss, Vol. 2: Separation, Anxiety and Anger. London, Hogarth Press, 1973
79.
Shear MK : Exploring the role of experiential avoidance from the perspective of attachment theory and the dual process model. Omega (Westport) 2010 ; 61 : 357 – 369
80.
Tal I, Mauro C, Reynolds CF III, et al : Complicated grief after suicide bereavement and other causes of death. Death Stud 2017 ; 41 : 267 – 275
81.
Baker AW, Keshaviah A, Horenstein A, et al : The role of avoidance in complicated grief: a detailed examination of the Grief-Related Avoidance Questionnaire (GRAQ) in a large sample of individuals with complicated grief. J Loss Trauma 2016 ; 21 : 533 – 547
82.
Wittouck C, Van Autreve S, De Jaegere E, et al : The prevention and treatment of complicated grief: a meta-analysis. Clin Psychol Rev 2011 ; 31 : 69 – 78
83.
Stroebe M, Schut H : The dual process model of coping with bereavement: a decade on. Omega (Westport) 2010 ; 61 : 273 – 289
84.
Supiano KP, Luptak M : Complicated grief in older adults: a randomized controlled trial of complicated grief group therapy. Gerontologist 2014 ; 54 : 840 – 856
85.
Bryant RA, Kenny L, Joscelyne A, et al : Treating prolonged grief disorder: a randomized clinical trial. JAMA Psychiatry 2014 ; 71 : 1332 – 1339
86.
Boelen PA, de Keijser J, van den Hout MA, et al : Treatment of complicated grief: a comparison between cognitive-behavioral therapy and supportive counseling. J Consult Clin Psychol 2007 ; 75 : 277 – 284
87.
Litz BT, Schorr Y, Delaney E, et al : A randomized controlled trial of an Internet-based therapist-assisted indicated preventive intervention for prolonged grief disorder. Behav Res Ther 2014 ; 61 : 23 – 34
88.
Wagner B, Hofmann L, Maaß U : Online-group intervention after suicide bereavement through the use of webinars: study protocol for a randomized controlled trial. Trials 2020 ; 21 : 45
89.
Rosner R, Rimane E, Vogel A, et al : Treating prolonged grief disorder with prolonged grief-specific cognitive behavioral therapy: study protocol for a randomized controlled trial. Trials 2018 ; 19 : 241
90.
Szuhany KL, Young A, Mauro C, et al : Impact of sleep on complicated grief severity and outcomes. Depress Anxiety 2020 ; 37 : 73 – 80
91.
Trauer JM, Qian MY, Doyle JS, et al : Cognitive behavioral therapy for chronic insomnia: a systematic review and meta-analysis. Ann Intern Med 2015 ; 163 : 191 – 204
92.
Cunningham JEA, Shapiro CM : Cognitive behavioural therapy for insomnia (CBT-I) to treat depression: a systematic review. J Psychosom Res 2018 ; 106 : 1 – 12
93.
Inati V, Matic M, Phillips C, et al : A survey of the experiences of families with bereavement support services following a perinatal loss. Aust N Z J Obstet Gynaecol 2018 ; 58 : 54 – 63
94.
Linde K, Treml J, Steinig J, et al : Grief interventions for people bereaved by suicide: a systematic review. PLoS One 2017 ; 12 : e0179496
95.
Näppä U, Björkman-Randström K : Experiences of participation in bereavement groups from significant others’ perspectives; a qualitative study. BMC Palliat Care 2020 ; 19 : 124
96.
Tsai WI, Prigerson HG, Li CY, et al : Longitudinal changes and predictors of prolonged grief for bereaved family caregivers over the first 2 years after the terminally ill cancer patient’s death. Palliat Med 2016 ; 30 : 495 – 503
97.
Mason TM, Tofthagen CS, Buck HG : Complicated grief: risk factors, protective factors, and interventions. J Soc Work End Life Palliat Care 2020 ; 16 : 151 – 174
98.
Bui E, Nadal-Vicens M, Simon NM : Pharmacological approaches to the treatment of complicated grief: rationale and a brief review of the literature. Dialogues Clin Neurosci 2012 ; 14 : 149 – 157
99.
Jacobs SC, Nelson JC, Zisook S : Treating depressions of bereavement with antidepressants. A pilot study. Psychiatr Clin North Am 1987 ; 10 : 501 – 510
100.
Pasternak RE, Reynolds CF III, Schlernitzauer M, et al : Acute open-trial nortriptyline therapy of bereavement-related depression in late life. J Clin Psychiatry 1991 ; 52 : 307 – 310
101.
Zisook S, Shuchter SR, Pedrelli P, et al : Bupropion sustained release for bereavement: results of an open trial. J Clin Psychiatry 2001 ; 62 : 227 – 230
102.
Reynolds CF III, Miller MD, Pasternak RE, et al : Treatment of bereavement-related major depressive episodes in later life: a controlled study of acute and continuation treatment with nortriptyline and interpersonal psychotherapy. Am J Psychiatry 1999 ; 156 : 202 – 208
103.
Simon NM, Shear MK, Fagiolini A, et al : Impact of concurrent naturalistic pharmacotherapy on psychotherapy of complicated grief. Psychiatry Res 2008 ; 159 : 31 – 36
104.
Simon NM, Saxe GN, Marmar CR : Mental health disorders related to COVID-19-related deaths. JAMA 2020 ; 324 : 1493 – 1494
105.
Mayland CR, Harding AJE, Preston N, et al : Supporting adults bereaved through COVID-19: a rapid review of the impact of previous pandemics on grief and bereavement. J Pain Symptom Manage 2020 ; 60 : e33 – e39
106.
Eisma MC, Tamminga A, Smid GE, et al : Acute grief after deaths due to COVID-19, natural causes and unnatural causes: an empirical comparison. J Affect Disord 2021 ; 278 : 54 – 56
107.
Eisma MC, Tamminga A : Grief before and during the COVID-19 pandemic: multiple group comparisons. J Pain Symptom Manage 2020 ; 60 : e1 – e4
108.
Hall H : The effect of the COVID-19 pandemic on healthcare workers’ mental health. JAAPA 2020 ; 33 : 45 – 48
109.
COVID-19 Pandemic Guidance Document: Considerations for Healthcare Workers and Staff Exposed to COVID-19 Death and Dying. Arlington, VA, American Psychiatric Association, 2020. https://www.psychiatry.org/File%20Library/Psychiatrists/APA-Guidance-Death-Dying-in-Workplace.pdf. Accessed Nov 30, 2020
110.
COVID-19 Pandemic Guidance Document: Considerations for Family and Other Personal Losses Due to COVID-19-Related Death. Arlington, VA, American Psychiatric Association, 2020. https://www.deaconess.com/Services/Behavioral-Health/Documents-Behavioral-Health/APA-Guidance-Death-Dying-Personal-Bereavement-(1). Accessed Nov 30, 2020
111.
Rauch SAM, Simon NM, Rothbaum BO : Rising tide: responding to the mental health impact of the COVID-19 pandemic. Depress Anxiety 2020 ; 37 : 505 – 509
112.
Robinaugh DJ, LeBlanc NJ, Vuletich HA, et al : Network analysis of persistent complex bereavement disorder in conjugally bereaved adults. J Abnorm Psychol 2014 ; 123 : 510 – 522
113.
Robinaugh DJ, Millner AJ, McNally RJ : Identifying highly influential nodes in the complicated grief network. J Abnorm Psychol 2016 ; 125 : 747 – 757
114.
Maccallum F, Malgaroli M, Bonanno GA : Networks of loss: relationships among symptoms of prolonged grief following spousal and parental loss. J Abnorm Psychol 2017 ; 126 : 652 – 662
115.
Djelantik AAAMJ, Smid GE, Kleber RJ, et al : Symptoms of prolonged grief, post-traumatic stress, and depression after loss in a Dutch community sample: a latent class analysis. Psychiatry Res 2017 ; 247 : 276 – 281
116.
O’Connor MF, Wellisch DK, Stanton AL, et al : Craving love? Enduring grief activates brain’s reward center. Neuroimage 2008 ; 42 : 969 – 972
117.
Arizmendi B, Kaszniak AW, O’Connor MF : Disrupted prefrontal activity during emotion processing in complicated grief: an fMRI investigation. Neuroimage 2016 ; 124 : 968 – 976
118.
Saavedra Pérez HC, Ikram MA, Direk N, et al : Cognition, structural brain changes and complicated grief. A population-based study. Psychol Med 2015 ; 45 : 1389 – 1399
119.
Bui E, Hellberg SN, Hoeppner SS, et al : Circulating levels of oxytocin may be elevated in complicated grief: a pilot study. Eur J Psychotraumatol 2019 ; 10 : 1646603
120.
Mason TM, Duffy AR : Complicated grief and cortisol response: an integrative review of the literature. J Am Psychiatr Nurses Assoc 2019 ; 25 : 181 – 188

Information & Authors

Information

Published In

History

Published in print: Spring 2021
Published online: 17 June 2021

Keywords

  1. Bereavement
  2. Grief and mourning

Authors

Details

Kristin L. Szuhany, Ph.D. [email protected]
Department of Psychiatry, New York University Grossman School of Medicine, New York.
Matteo Malgaroli, Ph.D.
Department of Psychiatry, New York University Grossman School of Medicine, New York.
Carly D. Miron, B.A.
Department of Psychiatry, New York University Grossman School of Medicine, New York.
Naomi M. Simon, M.D., M.Sc.
Department of Psychiatry, New York University Grossman School of Medicine, New York.

Notes

Send correspondence to Dr. Szuhany ([email protected]).

Competing Interests

Dr. Malgaroli has received consulting fees from Groop Internet Platform. Dr. Simon reports speaking, continuing medical education, and consulting support from Aptinyx, Axovant Sciences, BehaVR, Genomind, Massachusetts General Hospital Psychiatry Academy, Praxis Therapeutics, Springworks, Vanda Pharmaceuticals, and Wiley (deputy editor of Depression and Anxiety); spousal equity support from G1 Therapeutics and Zentalis; and royalty support from American Psychiatric Association Publishing (Textbook of Anxiety, Trauma, and OCD-Related Disorders, 2020) and Wolters Kluwer (UpToDate). The other authors report no financial relationships with commercial interests.

Funding Information

Dr. Szuhany’s time for this review was supported by the National Center for Advancing Translational Science (NCATS) grant 5KL2-TR-001446-05. Dr. Malgaroli is the recipient of American Foundation for Suicide Prevention research grant PRG-0-104-19. Dr. Simon has received research grant support from the American Foundation for Suicide Prevention, U.S. Department of Defense, Patient-Centered Outcomes Research Institute, Highland Street Foundation, National Institutes of Health, and Cohen Veterans Network.

Metrics & Citations

Metrics

Citations

Export Citations

If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Simply select your manager software from the list below and click Download.

For more information or tips please see 'Downloading to a citation manager' in the Help menu.

Format
Citation style
Style
Copy to clipboard

View Options

View options

PDF/EPUB

View PDF/EPUB

Get Access

Login options

Already a subscriber? Access your subscription through your login credentials or your institution for full access to this article.

Personal login Institutional Login Open Athens login
Purchase Options

Purchase this article to access the full text.

PPV Articles - Focus

PPV Articles - Focus

Not a subscriber?

Subscribe Now / Learn More

PsychiatryOnline subscription options offer access to the DSM-5-TR® library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.

Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).

Media

Figures

Other

Tables

Share

Share

Share article link

Share